Review on SREBF1, with data on DNA, on the protein encoded and where the gene is implicated.
DNA/RNA
. (Figure 3 ). Regulates transcription of the LDL receptor gene as well as the fatty acid and cholesterol synthesis pathways. Binds to the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3'). Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3'). 
SREBF1 (sterol regulatory element binding transcription factor 1)

Description
The encoded protein is synthesized as a precursor that is initially attached to the nuclear membrane and endoplasmic reticulum. After cleavage, the mature protein translocates to the nucleus and activates transcription. This cleaveage is inhibited by sterols. Alternative promoter usage and splicing result in multiple transcript variants. 6 isoforms are described. Isoform 1A has been choosen as the canonical sequence (provided by RefSeq, Nov 2017). Quaternary structure of protein forms a tight complex with SCAP in the ER membrane. Efficient DNA binding of the soluble transcription factor fragment requires dimerization with another bHLH protein. Interacts with LMNA. Interacts with CEBPA, the interaction produces a transcriptional synergy (By similarity).
Post-translational modifications:
At low cholesterol the SCAP/SREBP complex is recruited into COPII vesicles for export from the ER. In the Golgi complex SREBPs are cleaved sequentially by site-1 and site-2 protease. The first cleavage by site-1 protease occurs within the luminal loop, the second cleavage by site-2 protease occurs within the first transmembrane domain and releases the transcription factor from the Golgi membrane. Apoptosis triggers cleavage by the cysteine proteases CASP3 and CASP7 (caspase-3 and caspase-7). Phosphorylated by AMPK (Protein kinase AMPactivated catalytic subunits), leading to suppress protein processing and nuclear translocation, and repress target gene expression. Phosphorylation at Ser-402 by SIK1 represses activity possibly by inhibiting DNA-binding. Ubiquitinatylated at Lys347, Lys379, Lys587, Lys675, Lys934, Lys1070.
Expression
Expressed in a wide variety of tissues, most abundant in fat and adrenal gland. In fetal tissues, 
Localisation
Endoplasmic reticulum membrane, golgi membrane, nuclear envelope, nucleoplasm, nucleus, COPIIcoated vesicle membrane.
Function
SREBF1 Transcription factor binds to the sterol regulatory element-1 (SRE1) (5-ATCACCCCAC-3) which is a motif found in the promoter of the low density lipoprotein receptor genes and other genes that involved in sterol biosynthesis. Depletion of cholesterol leads to intra-membrane proteolysis, releasing the active portion of SREBF1 containing the basic DNA-binding region from the endoplasmic reticulum membrane. After translocation to the nucleus and binding to its specific DNA sequences, SREBF1 dimers induce the expression of target genes involved in adipogenesis and membrane biogenesis (Nohturfft and Zhang, 2009 ).
Homology
SREBF1 gene is conserved in chimpanzee, Rhesus monkey, dog, cow, mouse, rat, chicken, zebrafish, fruit fly, mosquito and frog ( 
Implicated in
Endometrial Cancer (EC)
Higher level of SREBF1 has been detected in EC cells compared to the normal endometrium, and which was more prominent in higher-grade EC. NP (rs2297508) of SREBF-1 may serve as a genetic predisposition factor for the development of EC Qui et al., 2014).
Pancreatic Cancer
SREBF1 is highly expressed in pancreatic ductal cancer. The expression of SREBF1 is an independent risk factor affecting the overall survival of patients with pancreatic cancer (Sun et al., 2015 .
Hepatocellular Carcinoma (HCC)
SREBF1 expression is activated in HCC. Suppression of SREBF1 induced growth arrest and apoptosis whereas overexpression of SREBF1 enhanced cell proliferation in human HCC cell lines. There are a significant relationship between poor survival and high SREBF1 protein expression and correlation between high SREBF1 protein expression and high risk of mortality with statistical significance (Yamashita et al., 2008) .
Ovarian Cancer
SREBF1 protein expression was significantly higher in human ovarian cancer compared to benign and borderline ovarian tumors (Nie et al., 2013) .
Breast cancer
mRNA levels for SREBF-1c increase in a panel of primary human breast cancer samples (Yang et al., 2003) .
Colorectal Carcinoma
SREBF1 and FAS expression upregulated in colorectal carcinoma cells. It was hypothesized that, tumor cells recognize and respond to a deficiency in endogenous fatty acid synthesis by upregulating both SREBF1 and FAS expression and these findings support the model that SREBF1 participates in the transcriptional regulation of lipogenic genes in colorectal neoplasia (Li et al., 2000) .
Obesity and Obesity-related metabolic traits; Type 2 diabetes and Dyslipidemia
The SREBF1 molecular screening of 40 unrelated obese patients revealed 19 single nucleotide polymorphisms (SNPs). SNP17 (54G/C, exon 18c) is associated with morbid obesity. SNP3 (-150G/A, exon 1a), SNP5 (-36delG, exon 1a), and SNP17 are found in high linkage disequilibrium (D' > 0.8). The haplotype including wild-type alleles of these SNPs (C/G/G/T/C/G, HAP2) is identified as a risk factor for morbid obesity (P = 0.003).
In the obese group, SNP3, SNP5, and SNP17 are associated with male-specific hypertriglyceridemia (P = 0.07, P = 0.01, and P = 0.05, respectively). SNP17 is also associated with type 2 diabetes (P = 0.03) (Eberlé et al., 2004) . In addition, it was shown that insulin induces SREBF1 gene expression in isolated human adipocytes and skeletal muscle and also promotes SREBF1 cleavage in human isolated adipocytes. Common insulin-resistant states, such as obesity and type 2 diabetes, are characterized by decreased expression of SREBP1c mRNA (Sewter et al., 2002) .
